Vertex Pharmaceuticals Inc / Ma
- Stock
- Ticker VRTX
- ISIN US92532F1003
- Nasdaq
Performance, volatility and drawdowns of Vertex Pharmaceuticals Inc / Ma since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $57,835. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −41.6% in 10/2021, measured from the peak in 07/2020. It took 25 months to get back to the old peak.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 2,912 | 2,770 | 2,965 | 3,076 | 3,190 | 2,987 | 3,334 | 3,441 |
| Gross profit | 2,489 | 2,407 | 2,557 | 2,662 | 2,724 | 2,594 | 2,845 | 2,915 |
| Operating income | 1,026 | 630 | 1,151 | 1,186 | 1,206 | 1,138 | 1,247 | 713 |
| EBITDA | 1,073 | 679 | 1,203 | 1,240 | 1,262 | 1,194 | 1,303 | 782 |
| Net income | 913 | 646 | 1,033 | 1,083 | 1,191 | 1,031 | 1,100 | 654 |
| Earnings per share | 3.53 | 2.49 | 3.99 | 4.20 | 4.64 | 4.02 | 4.31 | 2.56 |
| Balance sheet | ||||||||
| Total assets | 22,533 | 22,881 | 24,037 | 24,862 | 25,643 | 26,484 | 27,423 | 32,736 |
| Liabilities | 6,124 | 6,384 | 6,861 | 7,544 | 6,977 | 7,123 | 7,175 | 11,829 |
| Equity | 16,410 | 16,496 | 17,175 | 17,319 | 18,666 | 19,362 | 20,248 | 20,907 |
| Cash | 4,570 | 4,675 | 4,972 | 4,940 | 5,085 | 5,493 | 6,144 | 4,979 |
| Long-term debt | – | – | – | – | 0.0 | – | – | 3,497 |
| Cash flow | ||||||||
| Operating cash flow | 585 | 819 | 1,073 | 1,241 | 498 | 1,428 | 1,125 | 643 |
| Capital expenditure | -93 | -41 | -146 | -102 | -149 | -133 | -112 | -97 |
| Free cash flow | 492 | 778 | 927 | 1,140 | 349 | 1,295 | 1,013 | 546 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2017 at +103.4%, weakest 2021 at −7.1%. 7 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 3 Nov 2026 | $2.56 |
| 4 Aug 2026 | $4.31 |
| 5 May 2026 | $4.02 |
| 13 Feb 2026 | $4.64 |
| 4 Nov 2025 | $4.20 |
| 5 Aug 2025 | $3.99 |
| 6 May 2025 | $2.49 |
| 13 Feb 2025 | $3.53 |
| 5 Nov 2024 | $4.01 |
| 2 Aug 2024 | −$13.92 |
| 7 May 2024 | $4.21 |
| 15 Feb 2024 | $3.71 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €118bn
- Market cap in trading currency
- $131bn
- Enterprise value
- $129bn
- P/E
- 33.2
- P/S
- 10.08
- P/B
- 6.25
- EV/Sales
- 9.94
- EV/EBITDA
- 28.4
- Earnings yield
- 3.0%
- FCF yield
- 2.5%
Results (last four quarters)
- Revenue
- $13.0bn
- Gross profit
- $11.1bn
- EBITDA
- $4.54bn
- Net income
- $3.98bn
- Earnings per share
- $15.53
- Revenue per share
- $51.08
- Revenue growth
- +11.8%
- Earnings growth
- −39.6%
Profitability
- Gross margin
- 85.5%
- Operating margin
- 33.2%
- Net margin
- 30.7%
- Return on equity
- 20.8%
- Return on assets
- 12.1%
Balance sheet and cash flow
- Cash
- $6.30bn
- Cash per share
- $24.86
- Financial debt
- $4.50bn
- Debt/equity %
- 22
- Current ratio
- 2.34
- Book value per share
- $82.46
- Operating cash flow
- $3.69bn
- Free cash flow
- $3.20bn
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 254m
- Volume
- 1.71m
- Avg. volume 3 months
- 1.24m
- Relative volume
- 1.4
Price and technicals
- Price
- $515.02
- 1 day
- −1.1%
- 52-week high
- $558.88
- 52-week low
- $422.32
- Distance to 52-week high
- −7.8%
- Distance to 52-week low
- +22.0%
- Distance to 50-day line
- −1.5%
- Distance to 200-day line
- +6.2%
- RSI (14)
- 41
- Volatility 1M
- 29.4%
Performance
- 1 week
- −4.4%
- 1 month
- −3.8%
- 3 months
- −5.9%
- 6 months
- +18.5%
- YTD
- +13.6%
- 1 year
- +22.3%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has VRTX performed since 11/2016?
$10,000 grew to $57,835 by 20 Nov 2026, which is +19.2% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is VRTX?
Volatility was 27.1% per year, measured on monthly returns. The largest decline from a peak was −41.6%, with the low in 10/2021.
How does VRTX compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, VRTX returned +19.2% at 27.1%. The correlation of monthly returns was 0.28; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.